ElevateBio Raises $401m To Fund Its Own And Partners’ Future Cell And Gene Therapy Needs

$1.3bn Invested In R&D, Manufacturing One-Stop Shop To Date

DNA helix 3D model
ElevateBio has gene editing, iPSC, vector, RNA and cell technology platforms • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business